Key result
Study evaluates diabetes and mortality risk in suspected ACS but omits specific results.
Why the study?
Does diabetes increase the risk of early and late death in suspected acute coronary syndrome patients with normal troponin-I levels?
Cohort (n=864)
Does diabetes increase the risk of early and late death in suspected acute coronary syndrome patients with normal troponin-I levels?
Diabetes may be an important high-risk indicator for early and late death in suspected ACS patients, even when troponin-I levels are normal.
Answers are grounded in this paper and cite their sources.
May support incorporating diabetes into risk stratification for troponin-negative suspected ACS; hypothesis-generating and requires prospective confirmation.
Clinicians use a variety of methods (1,2) to risk stratify patients with acute coronary syndromes (ACSs). Based on elevated risk, patients are often triaged to an aggressive strategy, including early angiography (3,4) and upstream use of intravenous glycoprotein IIb/IIIa inhibitors (5–7). The current American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines for the Management of Patients with Unstable Angina and Non-ST-segment Elevation Myocardial Infarction do not recognize diabetes as a high-risk ACS indicator. Therefore, we sought to clarify the relative risk of diabetes in early and late death in suspected ACS patients. In this study, a prospective registry of consecutive ACS patients with and without diabetes ( n = 864) was used. ACS was diagnosed as either myocardial infarction (8) or unstable angina (9) using standard definitions. Patients with ST-segment elevation myocardial infarction were excluded. All potential unstable angina patients who had a diagnostic angiographic, nuclear, or echocardiographic stress test that excluded obstructive coronary disease or who had an additional diagnostic study confirming an alternative explanation for presentation were excluded. Diabetes was defined by reported history or new antidiabetic therapy initiated during …
No takes yet. Share an insight, caveat, or question.
Marso et al. (2006) conducted a cohort in Suspected Acute Coronary Syndrome (n=864). Diabetes vs. No diabetes was evaluated on Early and late death. The study evaluated the relative risk of diabetes for early and late death in 864 suspected ACS patients, though specific results were not reported in the truncated abstract.
Synapse has enriched 10 related papers. Consider them for comparative context: